by Jones Day's PTAB Team | Nov 11, 2016 | Final Written Decisions, Pharmaceutical
By Irina Britva, Ph.D. and Cary Miller, Ph.D. On November 3, 2016, the PTAB issued a Final Written Decision upholding a Horizon Therapeutics LLC (“Horizon”) patent, U.S. 8,642,012 (the ’012 patent), relating to use of Ravicti® (glycerol phenylbutyrate) for treating...
by Matthew Johnson | Oct 13, 2016 | Final Written Decisions, Petitions, PTAB News, PTAB Trial Basics, Trial Institution
By Matt Johnson (profile) The Patent Trial and Appeal Board has released AIA trial filing and disposition numbers for August 2016. Filings remained near the 150 mark, with 143 total trials being requested in August, 136 of those being requests for Inter Partes Review....
